Breaking News Instant updates and real-time market news.

AMZN

Amazon.com

$1,495.60

-16.07 (-1.06%)

, VMW

VMware

$148.82

-4.34 (-2.83%)

07:43
11/21/18
11/21
07:43
11/21/18
07:43

AWS has long runway for future growth, says Oppenheimer

Oppenheimer analyst Timothy Horan says that Amazon Web Services (AMZN), AWS, continues to move up the stack improving Security, AI/ML, IoT, Database services and bundling in with infrastructure to maintain prices of legacy services. The analyst expects a number of new features and tools for Lambda, Aurora and Greengrass. He also sees Amazon discussing UC&C, gaming and blockchain. AWS kicked off its hybrid offering with its VMware (VMW) partnership and Kubernetes support, but it still lacks the full stack that Microsoft (MSFT) has for hybrid deployments-which are critical for enterprise customers that want to capture the benefits of the cloud while still maintaining on-premise datacenters for sensitive workloads, he contends. Overall, Horan believes demand remains strong, and thinks only about 25% of total enterprise workloads have moved to the cloud, which gives AWS a long runway for future growth.

AMZN

Amazon.com

$1,495.60

-16.07 (-1.06%)

VMW

VMware

$148.82

-4.34 (-2.83%)

MSFT

Microsoft

$101.67

-2.95 (-2.82%)

  • 26

    Nov

  • 28

    Nov

  • 28

    Nov

  • 29

    Nov

  • 04

    Dec

  • 04

    Dec

  • 05

    Dec

  • 06

    Dec

  • 10

    Jan

  • 03

    Mar

AMZN Amazon.com
$1,495.60

-16.07 (-1.06%)

11/16/18
KEYB
11/16/18
INITIATION
Target $110
KEYB
Overweight
Target initiated with an Overweight at KeyBanc
KeyBanc analyst Edward Yruma initiated Target (TGT) with an Overweight rating and $110 price target. The analyst says Target's investments and improved execution are driving stronger comps, telling investors in a research note that he thinks this is sustainable in the current environment. Rather than viewing Target as a participant in the Amazon (AMZN) vs. Walmart (WMT) battle, Yruma thinks its unique mix of consumables and high-margin apparel/home decor leave it well-positioned to take share from at-risk retailers.
11/16/18
MKMP
11/16/18
NO CHANGE
Target $415
MKMP
Buy
Netflix, Amazon price targets raised at MKM Partners
MKM Partners analyst Rob Sanderson raised his price targets on Buy rated Netflix (NFLX) and Amazon (AMZN) to $415 from $395 and $2,240 from $2,215 respectively as part of his broader research note titled "Victims of Risk-off Environment; Recommend Buying Weakness". The analyst states that these stocks have been among the weaker performers in the underperforming Internet sector, but should become "excellent performers" over the next 12 months if his view attributing the recent correction in the broader market to a late-cycle pause amidst geo-political uncertainty and Fed concerns proves to be correct. As part of this research note, Sanderson also keeps his Buy rating on Spotify (SPOT) but lowers its price target to $200 from $245, applying a 25-times forward earnings multiple in rolling out his valuation to 2022, with added currency related pressure against the "much less contentious" expected renewal rates in 2019.
11/19/18
JEFF
11/19/18
NO CHANGE
JEFF
Jefferies uncovers signs of Amazon expanding prescription drug presence
Jefferies analyst Brian Tanquilut says his proprietary checks of Amazon.com's (AMZN) moves in the pharmacy space indicate that the online retailer has finally made moves to expand PillPack. However, the initial expansion phase appears focused on offering pharmacy services to Amazon employees in Washington. In his most recent webscrape, Tanquilut came across a new prescription license in WA, two pending Rx licenses in New Mexico and Indiana, and pharmacy technician and packaging/shipping job postings all linked to PillPack's Phoenix facility. These new developments signal the beginning of Amazon's prescription expansion via PillPack, Tanquilut tells investors in a research note. If Amazon were to rollout a more extensive PillPack offering to its own employee base, Rite Aid (RAD) could be most exposed to potential script transfers with Walgreens Boots Alliance (WBA) the least exposed among the public drugstores, says the analyst. He still believes that the impact of Amazon's pharmacy entry will take a while to materialize for drug stores CVS Health (CVS) and Walgreens.
11/19/18
RBCM
11/19/18
INITIATION
Target $12
RBCM
Outperform
ADT Inc. initiated with an Outperform at RBC Capital
RBC Capital analyst Seth Weber initiated ADT Inc (ADT) with an Outperform rating and a price target of $12. The analyst cites the company's position as a leading provider in the $28B North America monitored security industry serving over 8M customers. Given the 27% short interest, Weber says ADT is a battleground stock, but he also believes that the perceived risk of competition from Amazon (AMZN) is overstated and that the company's big free cash flows outweighs its high leverage.
VMW VMware
$148.82

-4.34 (-2.83%)

10/29/18
MSCO
10/29/18
NO CHANGE
MSCO
IBM deal reinforces Morgan Stanley confidence in Hybrid Cloud emergence
After IBM (IBM) announced its intention to acquire Red Hat (RHT) for about $34B in a deal with an over 60% premium to Red Hat's Friday closing price, Morgan Stanley analyst Keith Weiss said the announcement reinforced both his confidence in the emergence of Hybrid Cloud architectures and the strength of IT spending into 2019. Red Hat has been Microsoft's (MSFT) primary competitor within server operating systems, and has generally been taking share, said Weiss, who thinks the longer-term opportunity or threat for Microsoft hinges on the ability of IBM to execute well and maintain the open source enthusiasm around the Red Hat distributions. For VMware (VMW) and Pivotal Software (PVTL), while Weiss sees little near-term impact, he adds that the proposed combination would likely result in a fiercer competitive environment going forward. For New Relic (NEWR), he sees little direct competitive impacts from the proposed merger. Given HortonWorks' (HDP) strong existing ties to IBM, Cloudera (CLDR) could benefit by becoming a preferred data management vendor within the OpenShift ecosystem, Weiss added.
11/14/18
CLVD
11/14/18
NO CHANGE
CLVD
Buy
Cleveland Research encourages investors to own VMware
VMware analyst Ben Bollin's checks indicate an uptick in Buy rated VMware performance with a number of partners exceeding target prior to quarter end. Billing remains favorable on VMware's near-term opportunity with favorable adoption of EUC, storage, compute, and networking and encourages investors to own shares. The analyst also said consensus estimates appear conservative and sees a number of catalysts that support +10.5% upside to FY20 revenue growth assumptions.
11/06/18
JEFF
11/06/18
NO CHANGE
Target $186
JEFF
Buy
VMware acquisition of Heptio makes sense, says Jefferies
Jefferies analyst John DiFucci believes VMware's acquisition of Heptio makes sense, as it "fits squarely into the company's broader Software-Defined Data Center strategy." The analyst believes VMware has adapted to the rising proliferation of container-based environments and he keeps a Buy rating on the shares with a $186 price target.
10/19/18
WEDB
10/19/18
INITIATION
Target $185
WEDB
Outperform
VMware initiated with an Outperform at Wedbush, added to Best Ideas List
Wedbush analyst Daniel Ives initiated VMware (VMW) with an Outperform rating and $185 price target and added the stock to the Best Ideas List. In a research note to investors, Ives says he believes VMware has a number of tailwinds heading into FY19 including a healthy ELA renewal cycle, strong customer interest around its vSphere solution as more enterprises aggressively embrace the cloud, and incremental growth from its NSX segment that we believe in particular could be a major growth driver for the coming years. With the current bid for Dell Technologies tracking stock (DVMT) undervaluing the inherent value of this stock, Ives believes an investor showdown is on the horizon as the Street joins forces in its battle vs. Michael Dell/Silver Lake in this path to take Dell public again and thus represents a potential wild card for VMware and its investors looking ahead.
MSFT Microsoft
$101.67

-2.95 (-2.82%)

11/12/18
LBOW
11/12/18
NO CHANGE
LBOW
Neutral
Earnings commentary shows 'ample evidence' of hyperscale caution, says Longbow
Longbow analyst Joe Wittine said that Microsoft (MSFT) signaled along with its earnings report that growth in investments would moderate, Amazon (AMZN) highlighted a focus on driving data center efficiencies, Alphabet (GOOGL) is understood to be eh "the largest driver" of Seagate's (STX) lowered outlook and Apple (AAPL) expects FY19 capex of $14B, down from this year's $16.7B. Wittine sees all of this as "ample evidence of increased caution in the hyperscale investment cycle," which leads his to believe his Neutral ratings on both Seagate and Western Digital (WDC) remain appropriate.
11/13/18
SUSQ
11/13/18
UPGRADE
Target $95
SUSQ
Positive
Xilinx upgraded to Positive with $95 price target at Susquehanna
As reported previously, Susquehanna analyst Christopher Rolland upgraded Xilinx (XLNX) to Positive from Neutral. The analyst likes the company's A.I. inference opportunity and its strong showing with Alveo. He said the early read on Alveo pricing puts it in the ballpark with Nvidia's (NVDA) T4. He is also encouraged that Microsoft (MSFT) may begin to dual source DC FPGAs, which was an opportunity that he thought had previously been locked up by Altera. Rolland raised his price target to $95 from $82 on Xilinx shares.
11/15/18
MSCO
11/15/18
NO CHANGE
MSCO
Morgan Stanley highlights four tech stocks to buy following recent pullback
Morgan Stanley analysts Katy Huberty, Keith Weiss, Brian Nowak, Joe Moore, James Faucette and Brian Essex collaborated on a report addressing technology stocks following the recent market pullback, contending the fact that technology sector concentration remains near all-time highs suggests that its "probably too early" to buy the sector broadly. However, they highlight four stocks - Alphabet (GOOGL), Take-Two Interactive (TTWO), Microsoft (MSFT) and Xilinx (XLNX) - for which they believe the pullback is not fundamentally driven and the companies have strong secular tailwinds. The firm's analyst call these four stocks their "highest conviction" names and maintain Overweight ratings on all four.
11/07/18
MAXM
11/07/18
NO CHANGE
Target $127
MAXM
Hold
Tableau price target raised to $127 from $107 at Maxim
Maxim analyst Nehal Chokshi raised his price target on Tableau (DATA) to $127 after its "solid" Q3 results that saw implied billings accelerate to 31% annualized growth in spite of the headwinds coming "from ongoing rapid transition to subscription model". The analyst also keeps his Hold rating on Tableau, stating that the December quarter outlook implies a billings deceleration to 17% while also noting that the company is facing a "lurking" competitive threat from Microsoft (MSFT).

TODAY'S FREE FLY STORIES

CSCO

Cisco

$44.25

0.04 (0.09%)

, AAOI

Applied Optoelectronics

$16.24

-0.89 (-5.20%)

13:05
12/18/18
12/18
13:05
12/18/18
13:05
Recommendations
Cisco, Applied Optoelectronics, Finisar analyst commentary  »

Luxtera buyout negative…

CSCO

Cisco

$44.25

0.04 (0.09%)

AAOI

Applied Optoelectronics

$16.24

-0.89 (-5.20%)

FNSR

Finisar

$21.76

0.2 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 04

    Mar

APHA

Aphria

$5.87

0.43 (7.90%)

13:05
12/18/18
12/18
13:05
12/18/18
13:05
Options
Aphria call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$46.15

-0.66 (-1.41%)

, ORCL

Oracle

$46.19

0.47 (1.03%)

13:01
12/18/18
12/18
13:01
12/18/18
13:01
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks started strong and…

CBS

CBS

$46.15

-0.66 (-1.41%)

ORCL

Oracle

$46.19

0.47 (1.03%)

JNJ

Johnson & Johnson

$131.92

2.81 (2.18%)

BA

Boeing

$330.55

14.17 (4.48%)

TLRY

Tilray

$73.29

7.4 (11.23%)

NVS

Novartis

$85.67

-0.13 (-0.15%)

NAV

Navistar

$26.72

2.88 (12.08%)

RCII

Rent-A-Center

$12.45

-2 (-13.84%)

LXFR

Luxfer

$17.87

-3.55 (-16.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 18

    Dec

  • 19

    Dec

  • 20

    Dec

  • 20

    Dec

  • 05

    Jan

  • 27

    Jan

ALB

Albemarle

$81.65

1.15 (1.43%)

12:57
12/18/18
12/18
12:57
12/18/18
12:57
Periodicals
Breaking Periodicals news story on Albemarle »

Albemarle named a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

12:56
12/18/18
12/18
12:56
12/18/18
12:56
Hot Stocks
DOJ says Germany's IAV GmbH to pay $35M fine for role in VW emissions fraud »

IAV GmbH, IAV, a German…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$12.41

-2.04 (-14.12%)

12:52
12/18/18
12/18
12:52
12/18/18
12:52
Upgrade
Rent-A-Center rating change  »

Rent-A-Center upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

MEET

Meet Group

$3.89

0.51 (15.09%)

12:50
12/18/18
12/18
12:50
12/18/18
12:50
Hot Stocks
Meet Group jumps almost 16% after rollout of Battles »

Shares of mobile social…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$88.17

0.09 (0.10%)

12:46
12/18/18
12/18
12:46
12/18/18
12:46
Hot Stocks
Duke Energy provides update on progress to close coal ash basins »

Duke Energy provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APEN

Apollo Endosurgery

$3.57

0.08 (2.29%)

12:45
12/18/18
12/18
12:45
12/18/18
12:45
Recommendations
Apollo Endosurgery analyst commentary  »

Apollo Endosurgery target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOPE

Grand Canyon

$104.20

-1.13 (-1.07%)

12:44
12/18/18
12/18
12:44
12/18/18
12:44
Recommendations
Grand Canyon analyst commentary  »

Barrington views Grand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOPE

Grand Canyon

$104.20

-1.13 (-1.07%)

12:43
12/18/18
12/18
12:43
12/18/18
12:43
Hot Stocks
Grand Canyon to acquire Orbis Education Services »

Before the market open,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWDP

DowDuPont

$53.15

1.46 (2.82%)

12:40
12/18/18
12/18
12:40
12/18/18
12:40
Options
Put spreads in Dow DuPont as shares gain 3% »

Put spreads in Dow DuPont…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAXR

Maxar Technologies

$12.33

0.05 (0.41%)

12:32
12/18/18
12/18
12:32
12/18/18
12:32
Hot Stocks
Maxar's SSL awarded contract to provide GEO satellite for Ovzon »

SSL, a Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAYX

Paychex

$64.72

-0.23 (-0.35%)

, GIS

General Mills

$37.18

0.45 (1.23%)

12:30
12/18/18
12/18
12:30
12/18/18
12:30
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PAYX

Paychex

$64.72

-0.23 (-0.35%)

GIS

General Mills

$37.18

0.45 (1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 19

    Dec

FDX

FedEx

$185.39

3.19 (1.75%)

, MU

Micron

$34.59

0.7 (2.07%)

12:30
12/18/18
12/18
12:30
12/18/18
12:30
Earnings
Notable companies reporting after market close »

Notable companies…

FDX

FedEx

$185.39

3.19 (1.75%)

MU

Micron

$34.59

0.7 (2.07%)

JBL

Jabil

$22.09

0.53 (2.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 18

    Dec

  • 18

    Dec

  • 08

    Jan

ALV

Autoliv

$73.57

1.8 (2.51%)

12:29
12/18/18
12/18
12:29
12/18/18
12:29
Downgrade
Autoliv rating change  »

Autoliv downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

XRX

Xerox

$21.25

-0.02 (-0.09%)

12:25
12/18/18
12/18
12:25
12/18/18
12:25
Options
Xerox call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

BPMUF

Basilea Pharmaceutica

$0.00

(0.00%)

12:25
12/18/18
12/18
12:25
12/18/18
12:25
Conference/Events
Cantor Fitzgerald pharma analysts to hold an analyst/industry conference call »

Pharmaceuticals analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

12:25
12/18/18
12/18
12:25
12/18/18
12:25
Conference/Events
Federal Reserve Board to hold a closed meeting »

The Federal Reserve holds…

GM

General Motors

$35.20

0.54 (1.56%)

12:23
12/18/18
12/18
12:23
12/18/18
12:23
Periodicals
GM to cut 50 jobs at Detroit lithium-ion battery assembly plant, Reuters reports »

General Motors will cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVH

PVH Corp.

$93.27

1.92 (2.10%)

12:21
12/18/18
12/18
12:21
12/18/18
12:21
Hot Stocks
PVH Corp. CEO Chirico acquires 10,000 shares for $95.51 »

PVH Corp. CEO Emanuel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/18/18
12/18
12:17
12/18/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/18/18
12/18
12:16
12/18/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOXO

XO Group

$35.00

0.015 (0.04%)

12:12
12/18/18
12/18
12:12
12/18/18
12:12
Hot Stocks
XO Group shareholders approve merger with WeddingWire »

XO Group announced that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$24.00

0.78 (3.36%)

12:05
12/18/18
12/18
12:05
12/18/18
12:05
Options
DSW call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.